Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Sci Adv ; 6(48)2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-33246963

RESUMEN

Artisanal and small-scale gold mining (ASGM) is the largest global source of anthropogenic mercury emissions. However, little is known about how effectively mercury released from ASGM is converted into the bioavailable form of methylmercury in ASGM-altered landscapes. Through examination of ASGM-impacted river basins in Peru, we show that lake area in heavily mined watersheds has increased by 670% between 1985 and 2018 and that lakes in this area convert mercury into methylmercury at net rates five to seven times greater than rivers. These results suggest that synergistic increases in lake area and mercury loading associated with ASGM are substantially increasing exposure risk for people and wildlife. Similarly, marked increases in lake area in other ASGM hot spots suggest that "hydroscape" (hydrological landscape) alteration is an important and previously unrecognized component of mercury risk from ASGM.


Asunto(s)
Mercurio , Compuestos de Metilmercurio , Monitoreo del Ambiente , Oro , Humanos , Minería , Ríos
3.
Transpl Immunol ; 30(4): 140-4, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24751756

RESUMEN

BACKGROUND: Indoleamine 2,3 dioxygenase (IDO) degrades the essential amino acid tryptophan and has been shown to minimize rejection in animal models of renal transplantation. Ischemia-reperfusion injury (IRI) is unavoidable in renal transplantation and correlates with shorter graft survival times. Despite its favorable effects on rejection, there is evidence that IDO may facilitate renal IRI. Differentiating the negative impact of IDO on IRI from its pro-tolerant effects in allograft rejection is of clinical relevance. In these studies we hypothesized that constitutive IDO activity may influence renal genes associated with recovery from IRI, and that IDO inhibition may unmask these effects. METHODS: We examined the renal transcriptome in a rat model of IRI with and without IDO inhibition with 1-methyl-d-tryptophan (1-MT), and assessed for alterations in the gene expression signature. RESULTS: These studies demonstrated that during recovery from renal IRI, pre-treatment with 1-MT alleviated alterations in 105 coding sequences associated with IRI, and in turn triggered new changes in 66 non-coding transcripts, the majority of which were represented by small nucleolar RNA. CONCLUSION: These results suggest a biologic role for non-coding, IDO-dependent genes in regulating the early response to IRI.


Asunto(s)
Lesión Renal Aguda/genética , Indolamina-Pirrol 2,3,-Dioxigenasa/antagonistas & inhibidores , ARN no Traducido/genética , Daño por Reperfusión/genética , Triptófano/análogos & derivados , Animales , Modelos Animales de Enfermedad , Rechazo de Injerto/tratamiento farmacológico , Supervivencia de Injerto , Riñón/patología , Trasplante de Riñón/efectos adversos , Masculino , Ratas , Ratas Sprague-Dawley , Transcriptoma/genética , Triptófano/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA